PetDx (Series B)
Funding Details
Awarder
Inbox
Date Award
December 9, 2021
Vertical
Molecular Diagnostics
Funding Amount
$62,000,000
Company Info
Founders
Daniel Grosu, MD, MBA
Market
Veterinary Health
Location
La Jolla, CA, USA
Coinvestors
Aperture Venture Partners, Declaration Partners, Friedman BioVentures, K4 Family Investments, LabCorp, Longview Asset Management, Torch Capital, Valor Equity Partners
Company Description

PetDx, The Liquid Biopsy Company for Pets is a San Diego-based molecular diagnostics company dedicated to unleashing the power of genomics to improve pet health. The company's flagship product, OncoK9, enables veterinarians to detect cancer in dogs with a simple blood draw.

Links